251 related articles for article (PubMed ID: 31496684)
21. Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation.
Lin T; Zhao X; Zhang Y; Lian H; Zhuang J; Zhang Q; Chen W; Wang W; Liu G; Guo S; Wu J; Hu Y; Guo H
Materials (Basel); 2016 Dec; 9(12):. PubMed ID: 28774123
[TBL] [Abstract][Full Text] [Related]
22. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.
Jeong KC; Kim KT; Seo HH; Shin SP; Ahn KO; Ji MJ; Park WS; Kim IH; Lee SJ; Seo HK
J Urol; 2014 Feb; 191(2):510-8. PubMed ID: 23872029
[TBL] [Abstract][Full Text] [Related]
23. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.
Nie S; Hsiao WL; Pan W; Yang Z
Int J Nanomedicine; 2011; 6():151-66. PubMed ID: 21499415
[TBL] [Abstract][Full Text] [Related]
24. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
25. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
[TBL] [Abstract][Full Text] [Related]
26. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and properties of folate receptor-targeted cationic liposomes].
Yan Y; Qi XR
Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
[TBL] [Abstract][Full Text] [Related]
29. Functional coating of liposomes using a folate- polymer conjugate to target folate receptors.
Watanabe K; Kaneko M; Maitani Y
Int J Nanomedicine; 2012; 7():3679-88. PubMed ID: 22888227
[TBL] [Abstract][Full Text] [Related]
30. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
[TBL] [Abstract][Full Text] [Related]
31. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
[TBL] [Abstract][Full Text] [Related]
32. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery.
GuhaSarkar S; More P; Banerjee R
J Control Release; 2017 Jan; 245():147-156. PubMed ID: 27913307
[TBL] [Abstract][Full Text] [Related]
33. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
34. Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: Invitro and invivo activity.
Nassir AM; Ibrahim IAA; Md S; Waris M; Tanuja ; Ain MR; Ahmad I; Shahzad N
Life Sci; 2019 Mar; 220():136-146. PubMed ID: 30710640
[TBL] [Abstract][Full Text] [Related]
35. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
36. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
37. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.
Nogawa M; Yuasa T; Kimura S; Tanaka M; Kuroda J; Sato K; Yokota A; Segawa H; Toda Y; Kageyama S; Yoshiki T; Okada Y; Maekawa T
J Clin Invest; 2005 Apr; 115(4):978-85. PubMed ID: 15761500
[TBL] [Abstract][Full Text] [Related]
38. Folate-conjugated rapamycin slows progression of polycystic kidney disease.
Shillingford JM; Leamon CP; Vlahov IR; Weimbs T
J Am Soc Nephrol; 2012 Oct; 23(10):1674-81. PubMed ID: 22859856
[TBL] [Abstract][Full Text] [Related]
39. Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone.
Le TP; Yu Y; Cho IS; Suh EY; Kwon HC; Shin SA; Park YH; Huh KM
J Korean Med Sci; 2023 May; 38(17):e135. PubMed ID: 37128878
[TBL] [Abstract][Full Text] [Related]
40. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
